Abstract. For elucidation of the mechanisms by which growth factors and cytokines affect renal epithelial cells, gene array analysis of renal cells cultured in the presence of transforming growth factor-␤1 (TGF-␤1) was performed. Many genes that were not previously considered to be involved in renal cell biologic processes were affected, one of which was jagged-1. The jagged ligand/notch receptor family controls the formation of boundaries between groups of cells and regulates cell fates. On the basis of the array analysis, jagged-1 expression was further evaluated in cultured cells and in C57BL/6 mice with a model of unilateral ureteral obstruction (UUO). Recombinant human TGF-␤1 increased jagged-1 mRNA levels at concentrations between 10 Ϫ11 and 10 Ϫ10 M. There was a commensurate increase in jagged-1 protein levels, as assessed by Western blotting. The expression of jagged-1 mRNA and protein was observed to be significantly increased in the kidneys of C57BL/6 mice with obstructed ureters, compared with the contralateral kidneys, at 7 and 14 d of UUO. Immunohistochemical analyses demonstrated jagged-1 expression in distal tubules of kidneys from normal mice or contralateral kidneys from mice with UUO. Jagged-1 protein expression was increased in tubules not yet in apparent atrophy in the kidneys with an obstructed ureter. Jagged-1 expression was significantly increased in the kidneys of normal mice treated with TGF-␤1 and was decreased in the kidneys of mice with UUO treated with a TGF-␤ receptor II-Fc chimera. These results suggest that jagged-1 is expressed in normal kidneys and that this expression is upregulated during renal disease, in a TGF-␤-dependent manner.
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Several molecular and cellular events that occur during the initiation and progression of kidney disease lead to the development of fibrosis of the tubulointerstitium. A number of studies have demonstrated that increased levels of angiotensin II (1, 2) , transforming growth factor-␤1 (TGF-␤1) (3, 4) , tumor necrosis factor-␣ (5-7), platelet-derived growth factor (8, 9) , fibroblast growth factor (10, 11) , and endothelin (12, 13) may have a role in the development and progression of kidney disease. Similarly, several studies have indicated that administration of renotrophic factors, such as insulin-like growth factor (14, 15) , hepatocyte growth factor (16, 17) , and bone morphogenic protein-7 (18, 19) , can ameliorate fibrotic kidney disease. Administration of renotrophic factors may restore factors that were previously lost because of decreased endogenous synthesis of such factors by the kidney. Those studies were hypothesis-driven, with each factor being investigated alone and generating downstream events that ultimately contributed to renal fibrosis or its reversal.
To more fully understand the molecular events initiated, sustained, or ameliorated by growth factors and cytokines within the kidney, we have taken advantage of gene array technology. This tool enables investigators to search broadly to identify changes in the activities of many genes, thus generating hypotheses for future studies. This procedure may reveal many changes in gene expression that were not previously known to be associated with the molecular or cell biologic processes of kidney cells. Our investigation was focused on the jagged ligand/notch receptor family. The effects of the profibrotic cytokine TGF-␤1 on the expression of genes within this family were determined in this study.
Materials and Methods

Cell Cultures
Human renal cortical epithelial cells (catalog no. CC-2554) were obtained as cryopreserved cells from Clonetics (San Diego, CA). Cells from one capsule were grown to confluence in collagen I-coated T75 flasks (Becton Dickinson, Franklin Lakes, NJ), in renal epithelial growth medium (REGM) (Clonetics). At confluence, cells were passaged by incubation in 0.025% trypsin/0.01% ethylenediaminetetraacetate (EDTA) for 2 min, at normal laboratory temperature. The cells were then frozen in REGM containing 5% DMSO and were stored in liquid nitrogen. Experiments described in this report used cells that had been thawed, cultured in REGM at 37°C in a humidified 95% air/5% CO 2 atmosphere, and passaged by trypsin/EDTA treatment for 2 min. Under these conditions, approximately 90% of the cells displayed a broad cobblestone appearance, whereas approximately 10% of the cells appeared in foci with a narrow cobblestone appearance.
All of the cells exhibited positive immunostaining for integrin-␣ 3 at their borders (data not shown). The discrete clusters of narrow cobblestone-appearing cells expressed integrin-␣ 2 at their borders (data not shown). In the kidney, distal tubule cells express integrin-␣ 2 (20) . This suggests that, under our cell culture and passage conditions, the predominant cell type seems to be of proximal tubule origin, with islands of distal tubule cells (20) . If, during cell passage, fresh REGM was added to the remaining cells after the 2-min incubation, the cell outgrowth exhibited characteristics of distal tubule cells (Morrissey J, unpublished observations). For the purposes of this study, cells were used at passages 2 to 4, with 2 min of trypsin/EDTA treatment. Cells were grown in REGM without or with human recombinant TGF-␤1 (T-7039; Sigma Chemical Co., St. Louis, MO), at the concentrations indicated.
In Vivo Experiments
The in vitro experiments using kidney cells in culture provided evidence that TGF-␤1 can regulate jagged-1 expression. We also tested whether this regulation occurs in vivo in mouse kidney. This assessment was performed using three different series of experiments.
In the first series, C57BL/6 mice received injections of either vehicle or recombinant human TGF-␤1 (catalog no. 240-B-010; R&D Systems, Minneapolis, MN). Mice received daily intraperitoneal injections of 10 g/kg for 6 d and were euthanized on day 7. Kidneys were collected for the preparation of RNA and for the histologic assessment of renal fibrosis. Ledbetter et al. (21) previously demonstrated that similar injections of TGF-␤2 caused fibrosis at the corticomedullary junction in a mouse model.
The second series of experiments used mice in a model of unilateral ureteral obstruction (UUO). This is a well characterized model of progressive renal fibrosis in which TGF-␤ has been implicated as a causative factor (3, 4) . The left ureter of C57BL/6 mice was ligated (7, 21) for either 7 or 14 d. Both kidneys were collected for preparation of total RNA and for immunohistochemical analyses.
The third series of experiments also involved C57BL/6 mice with UUO. These mice received intraperitoneal injections of either vehicle or recombinant mouse TGF-␤ receptor II (TGF-␤RII) extracellular domain fused to the human IgG Fc region (catalog no. 532-R2-060; R&D Systems). Mice were subjected to UUO and received an intraperitoneal injection of the soluble TGF-␤ receptor, at a dose of 1 mg/kg, on days 2, 4, and 6 before euthanasia on day 7 after UUO. This strategy of TGF-␤ suppression has been used in a mouse model of Alport's syndrome (22) . At euthanasia, the kidneys were collected for preparation of total RNA and for histologic assessments of renal fibrosis (23) .
At the time of euthanasia, portions of both kidneys of the experimental mice were placed in ice-cold phosphate-buffered saline. A thin (1-mm) coronal section of each kidney was obtained for histologic analysis. One pole of the kidney was homogenized in 2 ml of TriReagent (Sigma) for the preparation of total RNA (27) . The remaining pole of the kidney was frozen.
Analysis of RNA
At the time of collection (generally at 48 h of treatment), cells were quickly washed in ice-cold phosphate-buffered saline and then lysed in 1 ml of Tri-Reagent (Sigma). In some experiments, cells were collected 0, 3, 6, and 24 h after TGF-␤1 treatment. Total RNA was prepared as described previously (23) .
For gene analysis in this study, we used Human Cancer 1.2 arrays (catalog no. 7851-1; Clontech Laboratories, Palo Alto, CA). Total RNA from three separate series of cells in culture was treated with RNase-free DNase (Promega, Madison, WI). This RNA was radiolabeled with [ 33 P]dATP (Amersham-Pharmacia, Arlington Heights, IL), using protocols and primers provided by the manufacturer (Clontech). The radiolabeled cDNA was hybridized to the array membranes, which were quantified by phosphorimaging analysis with Optiquant software (Cyclone; Packard Instruments). TIFF files from the phosphorimaging analyses were processed with Photo-Paint (Corel version 9) and Scanalytics (freeware; Stanford University) software. We previously used autoradiography to assess gene expression in arrays (23) . The dynamic range of the grayscale for the autoradiographic results (approximately 2 log units) was not as great as that for phosphorimaging analyses (4 log units).
Reverse Transcription-PCR
The relative levels of jagged-1 mRNA were determined with reverse transcription (RT)-PCR based on the highly homologous sequences of human (Genbank accession no. AF028593), mouse (Genbank accession no. AF171092), and rat (Genbank accession no. L38483) mRNA. The primers consisted of 5'-TGGRTCTGTTGCTT-GGTGACRGCC-3' (sense) and 5'-CATYCGGTTYAAGCTCT-GGGC-3' (antisense) (where R is G or A and Y is C or T). Annealing was performed at 60°C for 1 min. The size of the product was 405 bp, and the product yielded the expected bands when digested with the restriction enzymes HaeIII, PvuII, and TaqI. RT-PCR was performed for 35 cycles for jagged-1 and for 28 cycles for glyceraldehyde-3-phosphate dehydrogenase (GAPDH); these values were within the linear range of amplification for each reaction (as determined in preliminary studies) when RNA was obtained from cells in culture. When RNA was obtained from kidneys, 28 cycles were used to amplify both jagged-1 and GAPDH. The primer pairs for amplification of GAPDH were as described previously (4, 6, 23) .
Immunochemical Jagged-1 Analyses
For Western blot analysis, cell monolayers were lysed with sodium dodecyl sulfate (SDS) sample buffer. Proteins in the lysate were separated by means of precast SDS gels containing 10% acrylamide (BioRad Laboratories, Richmond, CA). Proteins were transferred to nitrocellulose membranes, and jagged-1 was detected with antibody SC-6011 (Santa Cruz Biotechnology, Santa Cruz, CA). In separate gels and nitrocellulose membranes, cytoplasmic actin was detected with antibody SC-1616 (Santa Cruz Biotechnology). These primary antibodies were then detected with rabbit anti-goat IgG conjugated to alkaline phosphatase (catalog no. A-7187; Sigma). For immunohistochemical analyses, coronal sections of mouse kidneys were placed in Histochoice fixative (Amresco, Solon, OH). The sections were dehydrated, embedded in paraffin, cut into 4-m sections, dewaxed, and rehydrated as described previously (23) . The rehydrated sections were treated overnight at 4°C with a 1:100 dilution of anti-jagged-1 antibody (SC-6011), followed by rabbit anti-goat IgG conjugated to FITC (catalog no. F-7367; Sigma).
Additional Analytical Procedures
Sections of mouse kidney were examined for renal fibrosis with the Pico Sirius red staining technique. Briefly, deparaffinized sections were treated with 1% Sirius red in saturated picric acid (Sigma) and were destained in 0.01 N hydrochloric acid. Collagen fibrils stain red, whereas basement membrane collagen remains colorless. Five randomly selected fields (magnification, ϫ400) were evaluated for each kidney. Throughout this report, gene expression results are presented as means Ϯ SD. Comparisons between groups were performed with ANOVA, with P Յ 0.05 being considered significant.
Results
Array Analysis
A representative scatterplot depicting the relative levels of expression of 1176 genes by renal cortical epithelial cells is presented in Figure 1 , with a logarithmic scale indicating the individual mRNA levels. Even in this depiction, it is apparent that TGF-␤1 treatment of the cells did not produce widespread changes in gene expression; however, some gene activities were induced and some were repressed (Figure 1) . Most of the gene expression was clustered around the line of identity or within a twofold change from the identity line. The expression of all housekeeping genes was within the average range. From Figure 1 , it can be appreciated that the relative expression levels of genes in these cells spanned 4 orders of magnitude and approximately 10% of the measured genes were affected by TGF-␤1. The ability of the arrays to accurately reflect gene expression changes caused by TGF-␤1 was assessed by focusing on known effects. For example, TGF-␤1 is known to induce plasminogen activator inhibitor-1 (PAI-1), TGF-␤-inducible gene h3 (BIG-h3), and fibronectin (FN) (24) . A 3.96 Ϯ 0.53-fold increase in PAI-1 expression, a 4.08 Ϯ 0.52-fold increase in BIG-h3 expression, and a 2.60 Ϯ 0.38-fold increase in FN expression were observed when data from three separate cell cultures were evaluated ( Figure 1 and Table 1 ). The expression of these index genes was significantly above the identity Ϯ twofold change lines in Figure 1 . These data support the use of gene array technology to accurately assess changes in the activities of genes not conventionally associated with kidney cells or kidney cells treated with growth factors or cytokines. The expression of several genes was stimulated by TGF-␤1 treatment to extents similar to those for the index genes (PAI-1, BIG-h3, and FN). One gene, jagged-1, was observed to be stimulated 4.17 Ϯ 1.11-fold by TGF-␤1 and is the focus of this study.
These commercially available arrays contain several genes of the notch receptor/ligand/modifier family. A portion of Figure 1 was expanded, and the position of relative expression of these genes in the scatterplot is highlighted in Figure 2 . When data for three separate cell incubations (with separate array analyses) were averaged, the expression of these genes was observed to be stimulated by TGF-␤1 ( Figure 2 and Table  1 ). Members of this gene family include jagged-2, manic fringe, lunatic fringe, notch 1, notch 2, and notch 4. With the exception of the notch 2 gene, all members of the jagged/notch/ fringe family included in the Human Cancer 1.2 array were upregulated by TGF-␤1 treatment of human renal cortical epithelial cells in culture (Table 1) .
Jagged-1 Expression in Cultured Renal Cells
To confirm that TGF-␤1 treatment of human renal cortical epithelial cells in primary culture induced jagged-1 expression, we used RT-PCR. Primers were designed to take advantage of the near identity of the human, rat, and mouse jagged-1 sequences. Correct amplification of jagged-1 by these primers was confirmed by dideoxy-chain termination sequencing of the PCR product. These sequences were observed to be identical to the published sequences for human jagged-1 (GenBank accession no. AF02593). The renal cortical epithelial cells were treated without or with TGF-␤1 at concentrations of 10 Ϫ12 to 10 Ϫ9 M. Total RNA was prepared, converted to single-strand cDNA, and amplified by PCR for jagged-1 and GAPDH. The amounts of GAPDH mRNA in the cells were not observed to differ between the cell populations that were treated or not treated with different concentrations of TGF-␤1. The amounts of jagged-1 mRNA were observed to increase between 10 Ϫ12 and 10 Ϫ10 M TGF-␤1 (Figure 3) . In four separate concentration-response experiments and four additional paired control/10 Ϫ9 M TGF-␤1 incubations, treatment with TGF-␤1 was observed to stimulate jagged-1 mRNA synthesis 4.73 Ϯ 0.61-fold in these primary cultures of human renal cortical epithelial cells, as determined with RT-PCR. This compares with the 4.51 Ϯ 1.11-fold induction determined in array analyses of three separate cell incubations ( Table 1) .
The rapidity with which TGF-␤1 induced jagged-1 expression was next tested. Four different groups of human renal cortical epithelial cells were treated with 10 Ϫ10 M TGF-␤1, for 3, 6, 24, or 48 h. The cells were collected, total RNA was prepared, and jagged-1 mRNA levels were determined by RT-PCR. An example of one cell series is depicted in Figure 4 , which indicates that jagged-1 mRNA levels were significantly increased within 3 h after the addition of TGF-␤1. Figure 4 also indicates that no PCR product was formed when a source of cDNA was omitted from either the jagged-1 or GAPDH amplification reactions. Additionally, as indicated in Figure 3 , the amounts of GAPDH mRNA present in the cells were independent of the duration of TGF-␤1 treatment. As averaged for four different sets of cells, TGF-␤1 treatment increased jagged-1 expression by 2.66 Ϯ 0.25-fold at 3 h.
The cell layer was also lysed with SDS sample buffer, and the proteins were separated on acrylamide gels containing SDS. Proteins in the gels were transferred to nitrocellulose membranes, which were then incubated with a goat polyclonal antibody (SC-6011; Santa Cruz Biotechnology) that recognizes jagged-1 of human, rat, or mouse origin. The location of jagged-1 on the nitrocellulose membranes was observed with an alkaline phophatase-linked secondary antibody and a col- 
Jagged-1 Expression In Vivo
The results described above indicated that renal cells in primary culture expressed jagged-1 and expression was rapidly stimulated in vitro by TGF-␤1. The next step was to determine whether jagged-1 was expressed by kidneys in vivo and whether expression was altered in a renal disease model that was driven, in part, by an increase in TGF-␤1 levels. UUO is a model of progressive tubulointerstitial fibrosis of the kidney in which an increase in TGF-␤1 levels is a contributing factor (3, 4) . Single-stranded cDNA was prepared from total RNA extracted from both the contralateral unobstructed kidney and the kidney with an obstructed ureter in C57BL/6 mice after 7 d of UUO. Amplification of GAPDH mRNA was observed to be the same with cDNA prepared from the two types of kidneys. Amplification of jagged-1 mRNA, however, revealed a significant increase in the kidneys with an obstructed ureter ( Figure  6 ). RT-PCR analysis of jagged-1 mRNA from mice with UUO of 7-or 14-d duration revealed a 5.98 Ϯ 0.39-fold increase in jagged-1 expression in the kidney with an obstructed ureter, compared with the kidney without obstruction, in six different mice.
Sections of contralateral unobstructed kidneys and kidneys with an obstructed ureter were immunohistochemically examined, to locate jagged-1 expression. In the contralateral unobstructed kidneys, jagged-1 was observed to weakly stain the basolateral membrane of distal tubules and thick ascending limb segments (Figure 7) . There was weaker staining of proximal tubules, with no discernible staining of glomerular structures. A similar staining pattern was observed in sections of kidneys obtained from mice that had undergone a sham operation (data not shown). In the kidneys with an obstructed ureter, there was prominent staining of nondilated tubule segments. Dilated tubule segments displayed a flattened epithelium, which stained weakly for jagged-1 (Figure 7) . When kidney sections were not treated with primary antibody, there was no discernible fluorescence after treatment with the FITClinked secondary antibody (data not shown). The coronal sections of both the contralateral unobstructed kidney and the kidney with an obstructed ureter were routinely embedded in the same paraffin block. This technique minimizes differences in the immunohistochemical procedures between the two kidneys, so that differences in jagged-1 location and staining intensity are more representative, rather than technical.
Although an increase in TGF-␤1 levels is an important factor in the pathophysiologic processes of many renal diseases (3), other growth factors, vasoactive substances, and cytokines contribute to the overall process of renal fibrosis (1). We therefore sought to establish a more solid link between increased TGF-␤1 levels and increased jagged-1 expression. Ledbetter et al. (21) observed that daily injections of TGF-␤2 caused renal fibrosis in mice. With this strategy, normal mice received injections of 10 g/kg TGF-␤1 or vehicle for 6 d. The animals were euthanized on day 7, and jagged-1 mRNA contents were measured by RT-PCR. The jagged-1 mRNA content of the kidneys (normalized to the amount of GAPDH mRNA) was significantly increased (approximately 2.4-fold, P Ͻ 0.025) in the TGF-␤1-treated animals ( Figure 8A ). This suggests that an increase in circulating TGF-␤1 levels may be sufficient to increase jagged-1 expression in mouse kidneys.
Another series of experiments sought to eliminate the effects of TGF-␤1 via injection of the soluble TGF-␤ receptor into mice with UUO. This procedure was observed to blunt the effects of TGF-␤ in the progression of renal fibrosis in a mouse model of Alport's syndrome (22) . Mice received injections of soluble TGF-␤RII every other day through 7 d of UUO. The 2.8-fold increase in jagged-1 mRNA levels in the kidneys with an obstructed ureter that was observed in the vehicle-treated mice was significantly blunted in the TGF-␤RII-treated mice (P Ͻ 0.015) (Figure 8) .
The findings that TGF-␤1 treatment increased fibrosis in normal animals and TGF-␤RII treatment blunted fibrosis in the kidneys with an obstructed ureter are presented in Figure 9 . Kidney sections were stained with Pico Sirius red, which stains fibrils containing type I and III collagens. When mice were treated for 7 d with daily injections of 10 g/kg TGF-␤1, there was an increase in Pico Sirius red staining in the corticomedullary junction ( Figure 9A ), compared with similar kidney regions in vehicle-treated mice ( Figure 9B ). This is in keeping with the observations of Ledbetter et al. (21) after the injection of mice with TGF-␤2. In histologic sections of kidneys with an obstructed ureter, there was abundant Pico Sirius red staining in the cortical interstitium ( Figure 9C ). This Pico Sirius red staining was considerably diminished when mice with UUO were treated with TGF-␤RII-Fc ( Figure 9D ). 
Discussion
This investigation illustrates the utility of gene array technology for the identification of changes in the expression of genes not previously associated with kidney cells or kidney disease processes. Although this study eventually focused on jagged-1, changes in the expression of other members of the jagged/notch/fringe gene cluster attributable to the effects of TGF-␤1 were also detected.
The initial focus of this study was to define the utility of array technology in revealing new information on gene activity in kidney cells. During the course of the study, it was noted that a profibrotic cytokine, namely TGF-␤1, increased the expression of members of the jagged/notch/fringe cluster. This family of ligands, receptors, and receptor-modifying proteins is involved in the determination of cell fates when groups of cells are developing boundaries (25) (26) (27) . Except for the identification of mutations in jagged-1 as the cause of Alagille syndrome (28) , there are no reports associating jagged-1 with renal homeostasis or renal fibrotic disease. Alagille syndrome is an autosomal dominant disorder that encompasses a spectrum of organopathies, the most prominent of which is intrahepatic cholestasis with varying degrees of renal abnormalities (28) . The initial descriptions of this syndrome may have underreported the renal manifestations, inasmuch as recent studies indicated 50 to 80% renal involvement (29, 30) . When renal pathologic features were reported, the most common features were hypoplasia, hydronephrosis, and cystic lesions (29, 30) . Our results indicated that, in a mouse model of hydronephrosis, jagged-1 expression was dramatically increased. It is possible that the hydronephrotic appearance of the kidneys in Alagille syndrome is not a direct result of the absence of jagged-1 and that there is no linkage between gross or microscopic appearance and this molecular defect. The rodent model of hydronephrosis is produced by UUO.
The developmental pattern or differentiation state of cells expressing notch receptors is determined by the expression of ligands such as jagged-1 by neighboring cells. This is particularly true at gene expression boundaries, which can exist in a complex organ such as the kidney during development or during renal disease. Notch receptors and their ligands deter- mine many crucial cell fate decisions in many organ systems and may affect functions that are not yet fully understood (31) . Because ligands for the notch receptors include multiple forms of Serrate, Delta, and jagged, cell fate may be determined by the types and amounts of ligands expressed on adjacent cells (31) . This ligand redundancy could lead to deceptive phenotypes for jagged-1-knockout mice. For example, jagged-1 expression in human embryos is correlated with the sites of developmental defects observed in Alagille syndrome, with the exception of the nervous system (32, 33) . Homozygous jagged-1-knockout mice die as embryos as a result of hemorrhage (34) . Heterozygous jagged-1-null mice exhibit eye defects but not hepatic or cardiac defects; these findings do not strictly mimic the findings for patients with Alagille syndrome. It is possible that other notch receptor ligands expressed in the liver, heart, and vasculature of mice compensate for the haplodeficiency in jagged-1 expression in these mice. No renal phenotype was reported for the jagged-1-knockout mouse model (34) .
Treatment of keratinocytes in culture with TGF-␤1 was recently observed by Zavadil et al. (35) to increase jagged-1 expression in as little as 2 h. Our observations and those of Zavadil et al. (35) are similar in two respects, although different cell types were used. First, overall, TGF-␤1 caused the modulation of approximately 10% of the genes that were screened in each study. Second, in each case, jagged-1 was rapidly and significantly upregulated. Epithelial/mesenchymal plasticity is a feature of renal cell differentiation during development and dedifferentiation during fibrotic disease processes. TGF-␤1 induction of jagged-1 in the keratinocytes was hypothesized to maintain the epithelial cells in a transitional progenitor cell state (35) . Whether this is a function of jagged-1 in renal disease remains to be determined.
The process of glomerulogenesis seems to involve interactions between notch 2 and jagged-1. Notch 2-null mice fail to develop glomeruli at a stage involving capillary tuft formation (36) . Several recent studies suggested that jagged-1 interactions with notch receptors are involved in endothelial cell differentiation (37, 38) , endothelial cell injury (39, 40) , and angiogenesis (41) . During the progression of renal fibrosis in the UUO model, there is progressive isolation of peritubular capillaries from the tubules undergoing atrophy (42) . The observed loss of or lack of jagged-1 expression by atrophic tubules in the kidneys with an obstructed ureter may be a factor contributing to the loss of capillaries, with an attendant loss of renal function.
The pathophysiologic process of renal fibrosis that results from ureteral obstruction is driven in part by TGF-␤1. In this investigation, we observed that TGF-␤1 stimulated the expression of jagged-1, jagged-2, notch 1, notch 4, manic fringe, and lunatic fringe 2.2-to 4.2-fold. Notch 2 expression was not affected by TGF-␤1 during the study period (up to 48 h of culture). The in vitro observations with respect to jagged-1 were conveyed to an in vivo model of kidney disease. The significance of the jagged/notch/fringe family of ligands/receptors/receptor-modifying enzymes in kidney development or kidney disease has not been extensively explored. Recent reports suggested that notch signaling controls cell patterning in the developing pronephros (43) and in glomerulogenesis (36) . It remains to be determined whether profibrotic cytokines or profibrotic factors other than TGF-␤1 affect jagged-1 expression. In this regard, it should be noted that the UUO model involves nuclear factor-B activation (2, 7, 42, 44) , as do a number of models of renal disease [as recently reviewed by Guijarro and Egido (45) ]. The expression of jagged-1 has been observed to be upregulated by c-Rel (46) . This suggests that some crosstalk between the notch and nuclear factor-B signaling systems may occur. Additional studies are needed to determine whether jagged-1 expression in adult kidneys is profibrotic or an antifibrotic countermeasure in the progression of renal disease.
